Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

What is gemtesa?

See the DrugPatentWatch profile for gemtesa

What is Gemtesa (vibegron)?

Gemtesa is a prescription medicine for overactive bladder. Its active ingredient is vibegron, which is taken by mouth to help reduce urinary urgency and frequent urination. It works by affecting receptors involved in bladder signaling that contributes to overactive bladder symptoms. [1]

What does Gemtesa treat?

Gemtesa is used in adults with symptoms of overactive bladder, such as:
- Urgent need to urinate
- Frequent urination

How is Gemtesa used?

Gemtesa is a once-daily oral medication (tablet), taken as prescribed by a clinician as part of overactive bladder management. [1]

How does Gemtesa differ from other overactive bladder drugs?

Gemtesa (vibegron) is a beta-3 adrenergic agonist. That distinguishes it from antimuscarinics, another common class used for overactive bladder, which act by blocking muscarinic receptors instead. This different mechanism can matter for side effects and suitability for particular patients. [1]

Source

1 Drugs.com – Gemtesa (vibegron) information



Other Questions About Gemtesa :

When will there be a generic for gemtesa? Gemtesa patent expiration date? Is gemtesa better than myrbetriq? When will gemtesa be generic? When does gemtesa go generic? Gemtesa? Is gemtesa covered by medicare part d?